Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Di Silvio resigns as Pyng CEO

This article was originally published in Clinica

Executive Summary

Robert Di Silvio has resigned as president and CEO of emergency trauma care and resuscitation firm Pyng Medical. His resignation is effective as of 30 September, after which he will join an unnamed medical company based in the San Francisco Bay area. Mr Di Silvio will remain as a member of Pyng’s board of directors. Mark Hodge will become Pyng’s interim president and CEO on 1 October, a role he is expected to hold for six months. Mr Hodge is a management consultant that has been working with Pyng since June 2009. He previously worked for Medtronic and Boston Scientific in a marketing, operations and engineering capacity.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT095654

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel